Report
Description
Report Description
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic
acid molecules with a high specificity. Aptamers are generated rapidly and applied in the
inhibition, specific detection, and characterization of proteins. Aptamers can be used as
detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small
molecules, and other aptamers. Aptamers can be engineered to have higher affinity and
specificity to large number of targets. Aptamers can be selected from pools of random-sequence
oligonucleotides to bind a wide range of bio medically relevant proteins with affinities and
specificities that are comparable to antibodies. Aptamers are versatile and cost effective which
offer complementary or alternative solutions to the antibodies.Aptamers exhibit significant
advantages relative to protein therapeutics in terms of size, synthetic accessibility and
modification by medicinal chemistry. The effectiveness of aptamers and low manufacturing
costs can bring treatment for diseases like HIV or AIDS to the poorest countries. Aptamers can
be developed faster than antibodies, therefore diseases can be cured even faster.
Aptamers Market: Drivers and Restraints
Global Aptamers market is continue to witness positive growth owing to higher research and
development activities and investments in pharmaceutical and biotechnological companies.
Technological advancement and the patent expiration of systematic evolution of ligands by
exponential enrichment technology (SELEX) will boost this market positively. With the advent of
new technologies in aptamers market which brought cost to more economical level and higher
efficiency of aptamers in binding to larger molecules compared to antibodies will help to bolster
growth of aptamers market. Growing use of aptamers in drug discovery and disease treatment
may impact this market positively over forecasted period.